Information Library
Get to market faster - Market Access
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Orphan Drugs in the U.S.
June 24, 2009
Presentation by Dr. John Doyle, Market Access Practice Leader, from ISPOR 14th Annual International Meeting 2009(International Society for Pharmacoeconomics and Outcomes Research) on “Orphan Drugs' Market Access in the U.S.” -
Poised for success
June 16, 2009
Learn how a holistic life cycle approach can improve your commercial organization's productivity and flexibility -
Harnessing a Speciality Salesforce
March 26, 2009
NovaQuest’s predecessor, PharmaBio Development, committed more than $400 million in milestone payments and sales force services to fund the launch of Cymbalta and support commercialization efforts for five years. A dedicated service company created by PharmaBio Development is providing more than 500 Innovex sales representatives to supplement the extensive Lilly primary care and specialty sales forces. -
James C. Kirk
March 25, 2009
Jim joined Eidetics in 1988 from senior management positions in consumer and industrial product marketing, strategy, and development positions at Ocean Spray Cranberries and Gillette Company. Previously at Ocean Spray, Jim successfully spearheaded the company’s new Ingredient Division. -
Jacco Keja, Ph.D.
March 25, 2009
Jacco joined Quintiles Consulting in 2007 as Practice Leader, Market Access. Previously, Jacco was responsible for building Organon's global and local competence in Strategic and Operational Pricing, as well as expanding Health Economics and Outcomes Research. -
John Doyle, Dr. PH
March 25, 2009
John was president and a founder of Analytica International a global reimbursement, outcomes and market access consulting firm. He previously led the Oncology and Immunology Economics Research Group at Bristol-Myers Squibb. -
Matthew Eberhart
March 25, 2009
Matt is a proven business-building executive with a strong track record of implementing successful business development initiatives for consulting healthcare companies in both North America and Europe. -
Jay Norman
March 24, 2009
President – Quintiles Consulting Jay brings 25 years of experience in the consulting industry and a strong track record of growth, most recently with Diamond Management and Technology Consultants, where he served as President and Chief Operating Officer.
Page 1 of 1 (8 items)